Contact Us
Consumer Services or Programs
If your question is about a medical condition, then you should consult with a healthcare
professional or, in the case of an emergency, call 911 immediately.
Standard business hours for CSL Behring are 8:30 am to 5:00 pm Eastern time.
|
CSL Behring Headquarters
|
|
Phone:
|
610-878-4000
|
|
Fax:
|
610-878-4009
|
|
Location:
|
North America Headquarters
|
|
Address:
|
P.O. Box 61501
1020 First Avenue
King of Prussia, PA 19406 USA
|
|
|
|
Consumer Affairs
|
|
For Consumer Information
|
|
Phone:
|
888-508-6978
|
|
Fax:
|
610-878-4008
|
|
|
|
Medical Affairs
|
|
Phone:
|
800-504-5434
|
|
Fax:
|
610-878-4007
|
|
|
|
Adverse Events
|
|
Phone:
|
610-878-4193
|
|
Phone (After Business Hours): 866-915-6958
|
|
All fields marked with an asterisk (*) are required.
Important Safety Information
Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira® are not available.
Zemaira® may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.
In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).
Zemaira® is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.
Please see full prescribing information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
The information provided herein is solely for use by physicians and healthcare professionals in the United States. The CSL Behring product listed may not have been approved in other countries and may not be available everywhere.